
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
While infant abductions are rare, a few occur every year. Pediatricians should be aware of preventive steps to take in hospitals and how to educate parents in the art of protecting their newborns.






